Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-26-000094

Options or other derivatives

  • Principal Accounting Officer acquired 9,450 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Aneja Nikhil · Principal Accounting Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-09 Grant or award : show line 1 in the form Stock Option (Right to Buy) +9,450 9,450 D
Loading xslF345X05/form4.xml…